Video yükleniyor...

Video Yüklenemedi

Ana Sayfaya Dön

🫀 Detecting Diffuse Non-Calcified Coronary Atherosclerosis with Photon Counting CT: Seeing What Conventional CT Often Misses In coronary CTA, the hardest disease to detect is not focal stenosis. It’s diffuse, non-calcified atherosclerosis. No obvious narrowing. No calcium. Just subtle, continuous vessel wall involvement. This is where Photon-Counting CT (PCCT)...

FCademartiri's profile picture

Dr. Filippo Cademartiri

5,742 subscribers

11,254 görüntüleme • 6 ay önce •via X (Twitter)

LIVE

Anya Rossi• Live Now

Private livecam show

3 Yorum

sciqst profil fotoğrafı
sciqst6 ay önce

Photon counting CT certainly offers a fascinating advancement in visualizing non-calcified atherosclerosis. Its ability to discern details beyond conventional CT could revolutionize diagnostic capabilities in detecting coronary diseases. I'm curious, how do you see this impacting early intervention strategies? Will it lead to more personalized treatments given that non-calcified plaques might not be picked up by traditional methods? Enhancing our diagnostic toolkit feels like a step towards more precise #Medicine. For those intrigued by the nuances of coronary imaging, Sci-Quest is a one-stop platform for every biomedical question, where you can delve into comprehensive reviews and discussions. Check it out here: #Biomedicine #Innovation

meatpiped profil fotoğrafı
meatpiped6 ay önce

How does this change the clinical diagnosis? A standard CCTA will catch plaque buildup which means you need to start intensive lipid lowering therapy. That doesn’t change if you opt for a Photon counting CT. Either way your on high intensity statin and Nexlizet or PCKS9.

Dr. Filippo Cademartiri profil fotoğrafı
Dr. Filippo Cademartiri6 ay önce

The spatial resolution of PCCT is much higher and therefore you can see and characterize much earlier phases of the development of coronary atherosclerosis.

Benzer Videolar

🫀 Why Photon-Counting CT Is the New Standard for Non-Invasive Stent Imaging Because “Uninterpretable” Should No Longer Be Acceptable For years, coronary stent evaluation by CTA was often dismissed: “Too much blooming.” “Too much metal artifact.” “Just send the patient to invasive angiography.” That paradigm belongs to the past. Photon-Counting CT (PCCT) is changing non-invasive stent imaging from a limitation into a true diagnostic tool. 🧠 Why conventional CT struggles With standard EID-CT: - Metallic struts create significant blooming - Partial volume effects obscure the intrastent lumen - Small stents become nearly unreadable - Motion artifacts worsen proximal and ostial evaluation The result? 👉 Many stents are labeled “non-diagnostic” 👉 Patients are sent to unnecessary invasive angiography ⚡ Why PCCT changes everything -Ultra-high spatial resolution - Sharper visualization of stent struts - Clear assessment of the true intrastent lumen Reduced blooming artifacts - Metal appears closer to reality - Less artificial lumen narrowing High temporal resolution - Better imaging of proximal, ostial, and fast-moving segments - Reduced motion blur around the stent High iodine concentration contrast (400 mg I/mL) - Strong intraluminal enhancement - Better contrast between lumen and metal - Spectral capability Additional confidence separating iodine signal from stent artifact 🎯 The clinical shift From: “Can we read this stent?” To: “We can characterize it with confidence.” - Restenosis - Stent patency - Aneurysm repair - Complex proximal LAD interventions - Left main and bifurcation stents >>>> all become more reliably assessable. From invasive default to non-invasive confidence and convenience. From metallic blur to diagnostic clarity. That’s why PCCT is becoming the new standard for coronary stent imaging. ⚡🫀 #PhotonCountingCT #PCCT #CoronaryCTA #StentImaging #CardiacCT #CoronaryStent #UltraHighResolution #RadiologyInnovation #yesCCT
0:22

🫀 Why Photon-Counting CT Is the New Standard for Non-Invasive Stent Imaging Because “Uninterpretable” Should No Longer Be Acceptable For years, coronary stent evaluation by CTA was often dismissed: “Too much blooming.” “Too much metal artifact.” “Just send the patient to invasive angiography.” That paradigm belongs to the past. Photon-Counting CT (PCCT) is changing non-invasive stent imaging from a limitation into a true diagnostic tool. 🧠 Why conventional CT struggles With standard EID-CT: - Metallic struts create significant blooming - Partial volume effects obscure the intrastent lumen - Small stents become nearly unreadable - Motion artifacts worsen proximal and ostial evaluation The result? 👉 Many stents are labeled “non-diagnostic” 👉 Patients are sent to unnecessary invasive angiography ⚡ Why PCCT changes everything -Ultra-high spatial resolution - Sharper visualization of stent struts - Clear assessment of the true intrastent lumen Reduced blooming artifacts - Metal appears closer to reality - Less artificial lumen narrowing High temporal resolution - Better imaging of proximal, ostial, and fast-moving segments - Reduced motion blur around the stent High iodine concentration contrast (400 mg I/mL) - Strong intraluminal enhancement - Better contrast between lumen and metal - Spectral capability Additional confidence separating iodine signal from stent artifact 🎯 The clinical shift From: “Can we read this stent?” To: “We can characterize it with confidence.” - Restenosis - Stent patency - Aneurysm repair - Complex proximal LAD interventions - Left main and bifurcation stents >>>> all become more reliably assessable. From invasive default to non-invasive confidence and convenience. From metallic blur to diagnostic clarity. That’s why PCCT is becoming the new standard for coronary stent imaging. ⚡🫀 #PhotonCountingCT #PCCT #CoronaryCTA #StentImaging #CardiacCT #CoronaryStent #UltraHighResolution #RadiologyInnovation #yesCCT

Dr. Filippo Cademartiri

20,315 görüntüleme • 6 ay önce

PHOTON COUNTING "DEFEATS" CORONARY STENTS Coronary stents are everywhere. Tiny metal scaffolds that save lives, relieve symptoms, and silently sit inside millions of patients. And yet… when it comes to seeing through them, we’ve been struggling for years. Conventional CT (EiD) does a decent job with native coronary arteries. Until reality gets messy. - Calcifications. - Metal. - Blooming. - Artifacts. That’s where clarity fades—and uncertainty begins. And uncertainty is not neutral. It leads to overcalls, undercalls, unnecessary invasive angiographies… or worse, missed disease. Now something has changed. Photon Counting CT doesn’t just “improve” imaging. It changes the rules. - Higher spatial resolution. - True spectral information. - Less blooming. - More truth. Stents stop being blind spots. They become readable. For the first time, non-invasive follow-up of stented patients starts to make real clinical sense. Accurate, reliable, trustworthy. And once you see it, it’s hard to go back. #PhotonCountingCT #CardiacCT #CoronaryStents #CardiovascularImaging #MedTech #Radiology #Innovation
0:25

PHOTON COUNTING "DEFEATS" CORONARY STENTS Coronary stents are everywhere. Tiny metal scaffolds that save lives, relieve symptoms, and silently sit inside millions of patients. And yet… when it comes to seeing through them, we’ve been struggling for years. Conventional CT (EiD) does a decent job with native coronary arteries. Until reality gets messy. - Calcifications. - Metal. - Blooming. - Artifacts. That’s where clarity fades—and uncertainty begins. And uncertainty is not neutral. It leads to overcalls, undercalls, unnecessary invasive angiographies… or worse, missed disease. Now something has changed. Photon Counting CT doesn’t just “improve” imaging. It changes the rules. - Higher spatial resolution. - True spectral information. - Less blooming. - More truth. Stents stop being blind spots. They become readable. For the first time, non-invasive follow-up of stented patients starts to make real clinical sense. Accurate, reliable, trustworthy. And once you see it, it’s hard to go back. #PhotonCountingCT #CardiacCT #CoronaryStents #CardiovascularImaging #MedTech #Radiology #Innovation

Dr. Filippo Cademartiri

10,090 görüntüleme • 5 ay önce

PHOTON COUNTING CT is NOT a better CT It is a NEW imaging modality Photon Counting CT (PCCT) represents a transformative leap in medical imaging, not only as a molecular imaging modality but also as a technology offering ultra-high resolution and functional imaging capabilities. It is fundamentally more than just an enhanced version of traditional CT—PCCT introduces new ways of seeing and understanding the human body, providing critical insights at the molecular, structural, and functional levels. This positions PCCT as a unique imaging modality that requires a fresh approach to technical implementation, operational workflows, and financial planning. Despite the larger upfront investment, PCCT’s ability to drastically reduce downstream healthcare costs makes it a highly valuable investment in the long run. 1. Technical Innovations • Molecular Imaging and Energy Discrimination: Unlike traditional CT, which simply measures the total absorbed energy, PCCT counts individual X-ray photons and differentiates their energy levels. This allows for precise molecular imaging, revealing the composition of tissues and materials at a biochemical level. By distinguishing between different tissue types and contrast agents, PCCT opens up new diagnostic possibilities, such as identifying molecular biomarkers in tumors or distinguishing between stable and unstable plaque in coronary arteries. This capability shifts the focus of imaging from purely anatomical to both anatomical and molecular, offering more comprehensive diagnostic information. • Ultra-High Spatial Resolution: PCCT features significantly smaller detector elements compared to conventional CT scanners, allowing for ultra-high resolution imaging. This means clinicians can visualize fine structures such as microcalcifications in arteries, small lesions in soft tissues, or the intricate architecture of bones. This level of detail was previously unattainable with traditional CT. When combined with molecular imaging, this ultra-high resolution allows for the precise localization and characterization of disease at very early stages, which is essential for early diagnosis and intervention. • Functional Imaging Capabilities: PCCT also excels as a functional imaging modality. By capturing energy-resolved information, PCCT can provide insights into tissue functionality and dynamic physiological processes. For instance, it can detect changes in blood flow, tissue perfusion, and oxygenation without the need for additional contrast agents or scans. This functionality allows for real-time assessment of physiological processes, making it particularly valuable in cardiology, oncology, and neurology for evaluating organ function and monitoring disease progression. • Reduced Noise and Artifact Reduction: Photon-counting technology dramatically reduces electronic noise and imaging artifacts, such as beam hardening, resulting in clearer and more accurate images. The ability to deliver ultra-high resolution images with minimal artifacts improves diagnostic accuracy, reducing the need for repeat scans and ensuring that even subtle abnormalities are detected. 2. Operational Considerations • New Workflow for Molecular, High-Resolution, and Functional Imaging: The integration of molecular, ultra-high resolution, and functional imaging into routine clinical workflows introduces complexity that requires adaptation. Radiologists and technicians need specialized training to interpret and analyze multi-energy datasets that include molecular and functional information. PCCT produces a vast amount of detailed data, requiring clinicians to adopt new imaging protocols and refine their diagnostic approaches to fully leverage its capabilities. • Post-Processing and Data Management: PCCT generates richer, more complex datasets, which necessitates advanced post-processing tools and data management systems. Existing PACS and imaging software may not be equipped to handle such large volumes of data or to process functional and molecular information effectively. This means healthcare institutions must invest in robust IT infrastructure, including upgraded software and storage solutions, as well as provide additional training for staff on new imaging analysis techniques. • Revised Clinical Protocols: The molecular, functional, and ultra-high resolution imaging capabilities of PCCT will likely prompt changes in clinical protocols. For instance, the need for contrast agents may be reduced, simplifying patient preparation and decreasing the risk of adverse reactions. Additionally, the ability to monitor physiological functions in real-time through functional imaging could lead to more dynamic diagnostic procedures, such as assessing the effectiveness of interventions or treatments in real-time. 3. Financial Impact • Higher Initial Investment: PCCT systems are more expensive than traditional CT scanners due to their advanced technology, which includes photon-counting detectors and the computational power required for high-resolution, molecular, and functional imaging. While this upfront cost is significant, it is crucial to view it in the broader context of the downstream benefits and cost reductions that PCCT offers. • Downstream Cost Reductions: Although the initial capital investment is higher, PCCT’s ability to combine molecular, functional, and ultra-high resolution imaging leads to substantial reductions in downstream healthcare costs. Its superior diagnostic accuracy minimizes the need for follow-up tests, repeat scans, or invasive diagnostic procedures, such as diagnostic coronary angiographies. For example, in cardiology, PCCT can precisely differentiate between types of coronary plaque, reducing the need for invasive procedures to assess risk. • Lower Overall Healthcare Expenditures: By enabling earlier, more accurate diagnoses, PCCT can reduce the overall cost of patient care. Early detection of disease, particularly through its molecular and functional imaging capabilities, allows for more targeted treatments, potentially preventing the need for more aggressive and expensive interventions down the line. For instance, early-stage tumor detection via molecular imaging could lead to less invasive treatments, reducing hospital stays and improving patient outcomes, ultimately driving down healthcare costs. • Increased ROI Through Enhanced Patient Outcomes: Over time, the combination of molecular, functional, and ultra-high resolution imaging enhances diagnostic precision, which translates into better patient outcomes. Improved diagnostic accuracy reduces the incidence of unnecessary procedures, minimizes treatment delays, and results in more personalized and effective care. This leads to increased patient satisfaction, better healthcare outcomes, and greater patient throughput—all factors that improve the institution’s return on investment (ROI). • Competitive Advantage and New Revenue Streams: By adopting PCCT, healthcare institutions position themselves at the forefront of advanced imaging technologies. The ability to offer molecular, functional, and ultra-high resolution imaging creates a competitive advantage, attracting more complex and high-value cases. This can boost the institution’s reputation for excellence in diagnostics, leading to increased referrals, new patient populations, and expanded revenue opportunities. Summary Photon Counting CT (PCCT) is not just an evolution of existing CT technology—it is a molecular, ultra-high resolution, and functional imaging modality that fundamentally transforms the diagnostic landscape. Its ability to capture detailed molecular data, visualize minute anatomical structures with ultra-high resolution, and provide real-time functional imaging opens new possibilities for earlier and more precise diagnoses. While the financial investment in PCCT is larger, the reduction in downstream healthcare costs through improved diagnostic accuracy, fewer unnecessary interventions, and earlier disease detection far outweighs the initial expense. For institutions committed to advancing patient care and improving long-term financial outcomes, PCCT is an essential investment in the future of medical imaging. The video attached shows a patient accessing the Hospital for ACS. PCCT can provide ALL the imaging information of the concurrent imaging modalities (CXR, CAG, Echo, CMR) that you see around it... that's a lot! #PhotonCountingCT #MolecularImaging #UltraHighResolution #FunctionalImaging #FutureOfImaging #AdvancedMedicalImaging #EarlyDiseaseDetection #InnovativeCT #CuttingEdgeHealthcare #PrecisionDiagnostics #HealthcareInnovation #MedicalTechnology #CostEffectiveImaging #NextGenCT #PatientCareRevolution
1:10

PHOTON COUNTING CT is NOT a better CT It is a NEW imaging modality Photon Counting CT (PCCT) represents a transformative leap in medical imaging, not only as a molecular imaging modality but also as a technology offering ultra-high resolution and functional imaging capabilities. It is fundamentally more than just an enhanced version of traditional CT—PCCT introduces new ways of seeing and understanding the human body, providing critical insights at the molecular, structural, and functional levels. This positions PCCT as a unique imaging modality that requires a fresh approach to technical implementation, operational workflows, and financial planning. Despite the larger upfront investment, PCCT’s ability to drastically reduce downstream healthcare costs makes it a highly valuable investment in the long run. 1. Technical Innovations • Molecular Imaging and Energy Discrimination: Unlike traditional CT, which simply measures the total absorbed energy, PCCT counts individual X-ray photons and differentiates their energy levels. This allows for precise molecular imaging, revealing the composition of tissues and materials at a biochemical level. By distinguishing between different tissue types and contrast agents, PCCT opens up new diagnostic possibilities, such as identifying molecular biomarkers in tumors or distinguishing between stable and unstable plaque in coronary arteries. This capability shifts the focus of imaging from purely anatomical to both anatomical and molecular, offering more comprehensive diagnostic information. • Ultra-High Spatial Resolution: PCCT features significantly smaller detector elements compared to conventional CT scanners, allowing for ultra-high resolution imaging. This means clinicians can visualize fine structures such as microcalcifications in arteries, small lesions in soft tissues, or the intricate architecture of bones. This level of detail was previously unattainable with traditional CT. When combined with molecular imaging, this ultra-high resolution allows for the precise localization and characterization of disease at very early stages, which is essential for early diagnosis and intervention. • Functional Imaging Capabilities: PCCT also excels as a functional imaging modality. By capturing energy-resolved information, PCCT can provide insights into tissue functionality and dynamic physiological processes. For instance, it can detect changes in blood flow, tissue perfusion, and oxygenation without the need for additional contrast agents or scans. This functionality allows for real-time assessment of physiological processes, making it particularly valuable in cardiology, oncology, and neurology for evaluating organ function and monitoring disease progression. • Reduced Noise and Artifact Reduction: Photon-counting technology dramatically reduces electronic noise and imaging artifacts, such as beam hardening, resulting in clearer and more accurate images. The ability to deliver ultra-high resolution images with minimal artifacts improves diagnostic accuracy, reducing the need for repeat scans and ensuring that even subtle abnormalities are detected. 2. Operational Considerations • New Workflow for Molecular, High-Resolution, and Functional Imaging: The integration of molecular, ultra-high resolution, and functional imaging into routine clinical workflows introduces complexity that requires adaptation. Radiologists and technicians need specialized training to interpret and analyze multi-energy datasets that include molecular and functional information. PCCT produces a vast amount of detailed data, requiring clinicians to adopt new imaging protocols and refine their diagnostic approaches to fully leverage its capabilities. • Post-Processing and Data Management: PCCT generates richer, more complex datasets, which necessitates advanced post-processing tools and data management systems. Existing PACS and imaging software may not be equipped to handle such large volumes of data or to process functional and molecular information effectively. This means healthcare institutions must invest in robust IT infrastructure, including upgraded software and storage solutions, as well as provide additional training for staff on new imaging analysis techniques. • Revised Clinical Protocols: The molecular, functional, and ultra-high resolution imaging capabilities of PCCT will likely prompt changes in clinical protocols. For instance, the need for contrast agents may be reduced, simplifying patient preparation and decreasing the risk of adverse reactions. Additionally, the ability to monitor physiological functions in real-time through functional imaging could lead to more dynamic diagnostic procedures, such as assessing the effectiveness of interventions or treatments in real-time. 3. Financial Impact • Higher Initial Investment: PCCT systems are more expensive than traditional CT scanners due to their advanced technology, which includes photon-counting detectors and the computational power required for high-resolution, molecular, and functional imaging. While this upfront cost is significant, it is crucial to view it in the broader context of the downstream benefits and cost reductions that PCCT offers. • Downstream Cost Reductions: Although the initial capital investment is higher, PCCT’s ability to combine molecular, functional, and ultra-high resolution imaging leads to substantial reductions in downstream healthcare costs. Its superior diagnostic accuracy minimizes the need for follow-up tests, repeat scans, or invasive diagnostic procedures, such as diagnostic coronary angiographies. For example, in cardiology, PCCT can precisely differentiate between types of coronary plaque, reducing the need for invasive procedures to assess risk. • Lower Overall Healthcare Expenditures: By enabling earlier, more accurate diagnoses, PCCT can reduce the overall cost of patient care. Early detection of disease, particularly through its molecular and functional imaging capabilities, allows for more targeted treatments, potentially preventing the need for more aggressive and expensive interventions down the line. For instance, early-stage tumor detection via molecular imaging could lead to less invasive treatments, reducing hospital stays and improving patient outcomes, ultimately driving down healthcare costs. • Increased ROI Through Enhanced Patient Outcomes: Over time, the combination of molecular, functional, and ultra-high resolution imaging enhances diagnostic precision, which translates into better patient outcomes. Improved diagnostic accuracy reduces the incidence of unnecessary procedures, minimizes treatment delays, and results in more personalized and effective care. This leads to increased patient satisfaction, better healthcare outcomes, and greater patient throughput—all factors that improve the institution’s return on investment (ROI). • Competitive Advantage and New Revenue Streams: By adopting PCCT, healthcare institutions position themselves at the forefront of advanced imaging technologies. The ability to offer molecular, functional, and ultra-high resolution imaging creates a competitive advantage, attracting more complex and high-value cases. This can boost the institution’s reputation for excellence in diagnostics, leading to increased referrals, new patient populations, and expanded revenue opportunities. Summary Photon Counting CT (PCCT) is not just an evolution of existing CT technology—it is a molecular, ultra-high resolution, and functional imaging modality that fundamentally transforms the diagnostic landscape. Its ability to capture detailed molecular data, visualize minute anatomical structures with ultra-high resolution, and provide real-time functional imaging opens new possibilities for earlier and more precise diagnoses. While the financial investment in PCCT is larger, the reduction in downstream healthcare costs through improved diagnostic accuracy, fewer unnecessary interventions, and earlier disease detection far outweighs the initial expense. For institutions committed to advancing patient care and improving long-term financial outcomes, PCCT is an essential investment in the future of medical imaging. The video attached shows a patient accessing the Hospital for ACS. PCCT can provide ALL the imaging information of the concurrent imaging modalities (CXR, CAG, Echo, CMR) that you see around it... that's a lot! #PhotonCountingCT #MolecularImaging #UltraHighResolution #FunctionalImaging #FutureOfImaging #AdvancedMedicalImaging #EarlyDiseaseDetection #InnovativeCT #CuttingEdgeHealthcare #PrecisionDiagnostics #HealthcareInnovation #MedicalTechnology #CostEffectiveImaging #NextGenCT #PatientCareRevolution

Dr. Filippo Cademartiri

11,849 görüntüleme • 2 yıl önce

The SCAPIS study published in JAMA ~25,000 🇸🇪 participants, ~8 years follow-up. Adding coronary CT angiography #CCTA plaque information improved event prediction beyond clinical risk and calcium score. This is the first study showing the added value of CCTA on top of the calcium score for risk prediction. 🎯 What to look for: lipidic soft (non-calcified) plaque. 👀 Practical takeaway: Consider a CT angiography for risk stratification on top of the calcium score. Link: 🎥 Posting my avatar summarizing the study.
1:09

The SCAPIS study published in JAMA ~25,000 🇸🇪 participants, ~8 years follow-up. Adding coronary CT angiography #CCTA plaque information improved event prediction beyond clinical risk and calcium score. This is the first study showing the added value of CCTA on top of the calcium score for risk prediction. 🎯 What to look for: lipidic soft (non-calcified) plaque. 👀 Practical takeaway: Consider a CT angiography for risk stratification on top of the calcium score. Link: 🎥 Posting my avatar summarizing the study.

Carlos Collet MD PhD

20,171 görüntüleme • 9 ay önce

Let’s clear this up: Creatine is NOT just for men. It’s one of the most beneficial supplements for: ✔️ Brain function ✔️ Lean muscle ✔️ Recovery ✔️ Energy metabolism And women over 40 are often deficient in it.
1:32

Let’s clear this up: Creatine is NOT just for men. It’s one of the most beneficial supplements for: ✔️ Brain function ✔️ Lean muscle ✔️ Recovery ✔️ Energy metabolism And women over 40 are often deficient in it.

Gary Brecka

78,457 görüntüleme • 1 yıl önce

✅ CT Reveal – Teaching Case CT pulmonary angiography – Lung and soft-tissue windows In this 22-year-old male with acute hemoptysis and hemoglobin drop, CT shows: ✔ Focal pulmonary hemorrhage involving the right middle and lower lobes. ✔ Expansion of the bronchus intermedius filled with an endobronchial soft-tissue lesion. ✔ Hemorrhage is downstream to the obstructed bronchus, explaining the lobar distribution seen on chest X-ray. 🎥 Lung and mediastinal window clips demonstrate the airway abnormality clearly. This confirms that the bleeding source is airway-related, not primary parenchymal or pulmonary arterial disease. ⸻ ✅ Bronchoscopy and Final Diagnosis Bronchoscopy revealed a large intrabronchial blood clot, and the patient was referred to thoracic surgery with the diagnosis of: 👉 Bronchial Dieulafoy disease. ⸻ ✅ What is Bronchial Dieulafoy Disease? Bronchial Dieulafoy disease is a rare vascular anomaly of the bronchial wall characterized by: •A dilated, tortuous submucosal artery that protrudes into the bronchial lumen. •Normal surrounding mucosa until rupture occurs. •Sudden, often massive hemoptysis, usually in young or middle-aged patients. •CT may show only indirect signs (endobronchial filling, clot, focal hemorrhage), while bronchoscopy and angiography are key for diagnosis and treatment. 📌 Biopsy is dangerous because it can trigger catastrophic bleeding. 📌 Management includes bronchial artery embolization or surgical resection when needed. ⸻ ✅ Teaching Points ✔ Always differentiate focal versus diffuse pulmonary hemorrhage. ✔ Focal, lobar hemorrhage should prompt careful evaluation of the airways. ✔ CT angiography must be reviewed in both lung and mediastinal windows, tracking the bronchi. ✔ Rare entities like Bronchial Dieulafoy disease can mimic tumors or mucus plugs on CT.
0:20

✅ CT Reveal – Teaching Case CT pulmonary angiography – Lung and soft-tissue windows In this 22-year-old male with acute hemoptysis and hemoglobin drop, CT shows: ✔ Focal pulmonary hemorrhage involving the right middle and lower lobes. ✔ Expansion of the bronchus intermedius filled with an endobronchial soft-tissue lesion. ✔ Hemorrhage is downstream to the obstructed bronchus, explaining the lobar distribution seen on chest X-ray. 🎥 Lung and mediastinal window clips demonstrate the airway abnormality clearly. This confirms that the bleeding source is airway-related, not primary parenchymal or pulmonary arterial disease. ⸻ ✅ Bronchoscopy and Final Diagnosis Bronchoscopy revealed a large intrabronchial blood clot, and the patient was referred to thoracic surgery with the diagnosis of: 👉 Bronchial Dieulafoy disease. ⸻ ✅ What is Bronchial Dieulafoy Disease? Bronchial Dieulafoy disease is a rare vascular anomaly of the bronchial wall characterized by: •A dilated, tortuous submucosal artery that protrudes into the bronchial lumen. •Normal surrounding mucosa until rupture occurs. •Sudden, often massive hemoptysis, usually in young or middle-aged patients. •CT may show only indirect signs (endobronchial filling, clot, focal hemorrhage), while bronchoscopy and angiography are key for diagnosis and treatment. 📌 Biopsy is dangerous because it can trigger catastrophic bleeding. 📌 Management includes bronchial artery embolization or surgical resection when needed. ⸻ ✅ Teaching Points ✔ Always differentiate focal versus diffuse pulmonary hemorrhage. ✔ Focal, lobar hemorrhage should prompt careful evaluation of the airways. ✔ CT angiography must be reviewed in both lung and mediastinal windows, tracking the bronchi. ✔ Rare entities like Bronchial Dieulafoy disease can mimic tumors or mucus plugs on CT.

Dr Khaled Ahmed Abuzeid

11,889 görüntüleme • 9 ay önce

my brand new skin tint blurring elixir is almost here!!! 7.24!!!!! the way this looks like second skinnnn 🤤🤤 it has the lightweight look and feel of a skin tint with the performance of a long-lasting foundation. ✔️ Stays put without separating or getting patchy ✔️ Non-greasy, non-oily ✔️ Humidity and sweat-proof ✔️ Up to 12 hour wear Available in 24 shades 7.24 🤍 Kylie Cosmetics
0:22

my brand new skin tint blurring elixir is almost here!!! 7.24!!!!! the way this looks like second skinnnn 🤤🤤 it has the lightweight look and feel of a skin tint with the performance of a long-lasting foundation. ✔️ Stays put without separating or getting patchy ✔️ Non-greasy, non-oily ✔️ Humidity and sweat-proof ✔️ Up to 12 hour wear Available in 24 shades 7.24 🤍 Kylie Cosmetics

Kylie Jenner

252,285 görüntüleme • 2 yıl önce

The ECLIPSE Trial has completed enrollment with the randomization of 2000 patients. Dr. Philippe Généreux and I discuss the design of the trial in which vessel preparation strategies are compared in severely calcified coronary artery lesions.
9:06

The ECLIPSE Trial has completed enrollment with the randomization of 2000 patients. Dr. Philippe Généreux and I discuss the design of the trial in which vessel preparation strategies are compared in severely calcified coronary artery lesions.

C. Michael Gibson MD

15,029 görüntüleme • 3 yıl önce

This is the result of Dara doing solo performances ✔️ Stable voice ✔️ 💯 confidence ✔️🔝Stage presence ✔️ Confident in doing adlibs 2NE1 DARA IS BACK #WELCOMEBACK_2NE1 #투애니원_제일_잘_나가 Sandara Park
0:34

This is the result of Dara doing solo performances ✔️ Stable voice ✔️ 💯 confidence ✔️🔝Stage presence ✔️ Confident in doing adlibs 2NE1 DARA IS BACK #WELCOMEBACK_2NE1 #투애니원_제일_잘_나가 Sandara Park

deechoi🥀 WELCOME TO THE THANOS WORLD🫰

40,526 görüntüleme • 2 yıl önce

Vladimir Putin held a meeting of the Military-Industrial Commission today. Key points and quotes from the President of Russia at the meeting: ✔️ Russia is not facing fewer external threats. ✔️ The power in Kyiv is usurped by a "gang of embezzlers" who need a war to stay in power. ✔️ The regime in Ukraine cannot protect democracy because it itself has degenerated into a dictatorship. ✔️ Ukraine is supposedly offering to resume negotiations, but its actions are doing everything to prevent any negotiations from taking place. ✔️ Russia has no aggressive intentions towards Europe. ✔️ European leaders are using Ukrainians as cannon fodder. ✔️ NATO is expanding and growing, encroaching on various regions of the world. ✔️ Europeans are covering up their mistakes in economic policy by talking about a supposed threat from Russia. ✔️ Special attention in the new state program for armaments will be paid to the development of unmanned aerial vehicles. ✔️ A satellite constellation for high-speed internet access will allow for real-time control of troops. ✔️ The share of modern weapons in the Strategic Missile Forces is 92%. ✔️ Air defense must provide protection against any means of air attack. ✔️ Among the unconditional priorities of the new state program for armaments is the strengthening of the nuclear triad.
0:24

Vladimir Putin held a meeting of the Military-Industrial Commission today. Key points and quotes from the President of Russia at the meeting: ✔️ Russia is not facing fewer external threats. ✔️ The power in Kyiv is usurped by a "gang of embezzlers" who need a war to stay in power. ✔️ The regime in Ukraine cannot protect democracy because it itself has degenerated into a dictatorship. ✔️ Ukraine is supposedly offering to resume negotiations, but its actions are doing everything to prevent any negotiations from taking place. ✔️ Russia has no aggressive intentions towards Europe. ✔️ European leaders are using Ukrainians as cannon fodder. ✔️ NATO is expanding and growing, encroaching on various regions of the world. ✔️ Europeans are covering up their mistakes in economic policy by talking about a supposed threat from Russia. ✔️ Special attention in the new state program for armaments will be paid to the development of unmanned aerial vehicles. ✔️ A satellite constellation for high-speed internet access will allow for real-time control of troops. ✔️ The share of modern weapons in the Strategic Missile Forces is 92%. ✔️ Air defense must provide protection against any means of air attack. ✔️ Among the unconditional priorities of the new state program for armaments is the strengthening of the nuclear triad.

𝕊𝕡𝕣𝕚𝕟𝕥𝕖𝕣 𝕻𝕣𝕖𝕤𝕤

20,677 görüntüleme • 1 ay önce

From Can't to Can Do 11 years of Make in India has changed the game, turning dependence into dominance. ✔️ From imports to global exports in defence ✔️ From 2 to 300+ mobile factories ✔️ From proposals to India’s own semiconductor chip ✔️ With $749B FDI and a doubling of GDP in a decade India is not just making, it’s building, innovating, and leading the world. This is Aatmanirbhar Bharat in full swing! #11YearsOfMakeInIndia
1:15

From Can't to Can Do 11 years of Make in India has changed the game, turning dependence into dominance. ✔️ From imports to global exports in defence ✔️ From 2 to 300+ mobile factories ✔️ From proposals to India’s own semiconductor chip ✔️ With $749B FDI and a doubling of GDP in a decade India is not just making, it’s building, innovating, and leading the world. This is Aatmanirbhar Bharat in full swing! #11YearsOfMakeInIndia

MyGovIndia

17,761 görüntüleme • 1 yıl önce

🟩TIMI TIMI (Thrombolysis in Myocardial Infarction) flow is an angiographic grading system used to describe the degree of epicardial coronary blood flow after reperfusion therapy (thrombolysis or PCI) in acute myocardial infarction. It was developed by the TIMI study group to provide a standardized, reproducible way to assess coronary perfusion on angiography. TIMI flow grades 🟥TIMI 0: No perfusion There is no antegrade flow beyond the point of coronary occlusion. 🟪TIMI 1: Penetration without perfusion Contrast passes beyond the obstruction but fails to opacify the entire distal coronary bed and appears to stagnate. 🟦TIMI 2: Partial perfusion Contrast crosses the obstruction and opacifies the distal bed, but flow and/or clearance is slower than in normal or non-affected coronary segments. 🟩TIMI 3: Complete perfusion Normal antegrade flow with rapid filling and clearance of contrast in the distal coronary bed, comparable to an uninvolved vessel. Key point TIMI flow reflects epicardial coronary artery patency, not microvascular perfusion. Achieving TIMI 3 flow is strongly associated with better clinical outcomes after myocardial infarction. CardiovascularCorner
0:53

🟩TIMI TIMI (Thrombolysis in Myocardial Infarction) flow is an angiographic grading system used to describe the degree of epicardial coronary blood flow after reperfusion therapy (thrombolysis or PCI) in acute myocardial infarction. It was developed by the TIMI study group to provide a standardized, reproducible way to assess coronary perfusion on angiography. TIMI flow grades 🟥TIMI 0: No perfusion There is no antegrade flow beyond the point of coronary occlusion. 🟪TIMI 1: Penetration without perfusion Contrast passes beyond the obstruction but fails to opacify the entire distal coronary bed and appears to stagnate. 🟦TIMI 2: Partial perfusion Contrast crosses the obstruction and opacifies the distal bed, but flow and/or clearance is slower than in normal or non-affected coronary segments. 🟩TIMI 3: Complete perfusion Normal antegrade flow with rapid filling and clearance of contrast in the distal coronary bed, comparable to an uninvolved vessel. Key point TIMI flow reflects epicardial coronary artery patency, not microvascular perfusion. Achieving TIMI 3 flow is strongly associated with better clinical outcomes after myocardial infarction. CardiovascularCorner

CardiovascularCorner

11,031 görüntüleme • 9 ay önce

🐮Top tips from Dr. Temple Grandin on cattle handling design ✔️ Work on the edge of the flight zone ✔️ Curved race with solid gates ✔️ Non-slip flooring ✔️ Install solid sides ✔️ Avoid unnecessary distractions Video in full 👉
2:19

🐮Top tips from Dr. Temple Grandin on cattle handling design ✔️ Work on the edge of the flight zone ✔️ Curved race with solid gates ✔️ Non-slip flooring ✔️ Install solid sides ✔️ Avoid unnecessary distractions Video in full 👉

AHDB Beef & Lamb

10,982 görüntüleme • 3 yıl önce

✅ STILL AVAILABLE & truly one of the best pure PG’s in the state — amari addy. ✔️ He is QUICK + TWITCHY ✔️ He is a PURE PG (team first) ✔️ He is an ELITE defender (1-3 spots) ✔️ He is SMOOTH, CALM, COLLECTED ✔️ He is unbelievably COACHABLE ✔️ He plays at one of most decorated high school programs in Northwest Ohio 💡 Feel strongly that 2026 Amari Addy is as sure-fire of a scholarship athlete as there is in-class today (Ohio). Surrounded himself with SIX proven D1 teammates all spring and summer and PERFORMED!
0:44

✅ STILL AVAILABLE & truly one of the best pure PG’s in the state — amari addy. ✔️ He is QUICK + TWITCHY ✔️ He is a PURE PG (team first) ✔️ He is an ELITE defender (1-3 spots) ✔️ He is SMOOTH, CALM, COLLECTED ✔️ He is unbelievably COACHABLE ✔️ He plays at one of most decorated high school programs in Northwest Ohio 💡 Feel strongly that 2026 Amari Addy is as sure-fire of a scholarship athlete as there is in-class today (Ohio). Surrounded himself with SIX proven D1 teammates all spring and summer and PERFORMED!

Ohio Buckets

32,635 görüntüleme • 1 yıl önce

Appeasement with Iran is useless, we need: ✔️ real sanctions against the leadership ✔️ recognise Revolutionary Guard as terrorist organisation ✔️ reach out to opposition as real representatives of Iranian people ✊🏻
1:06

Appeasement with Iran is useless, we need: ✔️ real sanctions against the leadership ✔️ recognise Revolutionary Guard as terrorist organisation ✔️ reach out to opposition as real representatives of Iranian people ✊🏻

Guy Verhofstadt

136,836 görüntüleme • 2 yıl önce

"2009 is Golden Era of Kpop" Even they knew how that it's the peak of Kpop. The line up in Melon Top 100 chart is insane! ✔️ SNSD ✔️ 2NE1 ✔️ GD ✔️ 2PM ✔️ SUPER JUNIOR
0:59

"2009 is Golden Era of Kpop" Even they knew how that it's the peak of Kpop. The line up in Melon Top 100 chart is insane! ✔️ SNSD ✔️ 2NE1 ✔️ GD ✔️ 2PM ✔️ SUPER JUNIOR

deechoi🥀

21,705 görüntüleme • 2 ay önce

Awesome segment from Todd McShay podcast. ✔️ Ohio State defense is the Gold Standard in CFB. ✔️ Arvelle Reese best LB in the country. ✔️ Shocked that you lost 8 guys to the draft, and the defense is better. ✔️ Patricia has this front playing gap sound, nasty, and relentless.
7:35

Awesome segment from Todd McShay podcast. ✔️ Ohio State defense is the Gold Standard in CFB. ✔️ Arvelle Reese best LB in the country. ✔️ Shocked that you lost 8 guys to the draft, and the defense is better. ✔️ Patricia has this front playing gap sound, nasty, and relentless.

JBook.

147,254 görüntüleme • 1 yıl önce